Spire Healthcare Group PLC · LSE:SPI

Spire Healthcare — FY2017 Earnings Presentation

34 slides from Spire Healthcare's earnings presentation, 2018

  1. Slide 1: 2017 Financial Year Results Presentation

    2017 Financial Year Results Presentation www.spirehealthcare.com

  2. Slide 2: Disclaimer

    Disclaimer Important information: forward-looking statements These materials contain certain forward-looking statements relating to the business of Spire Healthcare Group plc (the “Company”) and its subsidiaries (collectively, the “Group”), including with respect to the progress, timing and completi

  3. Slide 3: Agenda

    Agenda 2017 Overview 1 Garry Watts, Chairman 2017 Financial Review 2 Andrew Goldsmith, HoF The Spire Opportunity 3 Justin Ash, CEO 3 www.spirehealthcare.com

  4. Slide 4: 2017 Overview

    2017 Overview Photo from AR 1 Garry Watts, Chairman 4 www.spirehealthcare.com

  5. Slide 5: Steady 2017 performance and a highly experienced CEO now in role

    2017 Overview Steady 2017 performance and a highly experienced CEO now in role A challenging year for Spire but our new CEO has a clear blueprint for growth and investment in the future  Senior management changes  A challenging year for Spire  Another change in NHS in H2 with eReferral flat vs 10

  6. Slide 6: 2017 performance in line with revised guidance

    2017 Overview 2017 performance in line with revised guidance Revenue & EBITDA Cashflow, Capex and Net debt  Revenue up overall by 0.6% on 2016 to £931.7m, with  Excellent cash conversion of EBITDA – 105.6% in 2017, third underlying revenue growth of 1.0% successive year >100%  Strong growth in Se

  7. Slide 7: Spire's network and strength

    2017 Overview Spire’s network and strength Spire is the largest UK independent hospital group by Revenues and EBITDA, with a comprehensive network of quality healthcare assets and services 69% of 134 operating 39 hospitals, hospitals rated 98% of patients theatres & 11 clinics and 1 “Good” rate “Exc

  8. Slide 8: 2017 Financial Review

    2017 Financial Review Photo from AR 2 Andrew Goldsmith, Head of Finance 8 www.spirehealthcare.com

  9. Slide 9: Trading headlines

    Financial Trading headlines Review 2017 Key drivers in 2017 delivering performance in line with revised guidance  Revenue up overall by 0.6% on 2016 to £931.7m with strong underlying growth in Self-Pay  Although In-patient and Daycase admissions fell 1.8% to 269,300, average revenue per case incre

  10. Slide 10: "Underlying" vs "Total"

    Financial “Underlying” vs “Total” Review 2017  Spire St Anthony’s – underwent significant cost base restructuring in H1 2017, and NHS local contract losses of £4m  Spire Manchester – transitioned from original site to new site during January 2017, and new site in ramp-up phase  Spire Nottingham –

  11. Slide 11: Financial highlights

    Financial Financial highlights Review 2017 2017 2016 Growth £m £m % Underlying Revenue 881.1 872.1 1.0% Non-Underlying Revenue 50.6 54.3 (6.8)% Group Revenue 931.7 926.4 0.6% 2017 Underlying Revenue mix 2016 Underlying Revenue mix 11 www.spirehealthcare.com

  12. Slide 12: Financial highlights

    Financial Financial highlights Review 2017 2017 2016 Growth £m £m % Underlying EBITDA 152.2 159.7 (4.7)% Non-Underlying EBITDA (2.2) 2.3 - Group EBITDA 150.0 162.0 (7.4)% 2017 2016 Underlying EBITDA margin 17.3% 18.3% Non-Underlying EBITDA margin (4.4)% 4.2% EBITDA margin 16.1% 17.5% 12 www.spirehea

  13. Slide 13: Revenue and admissions growth – Underlying

    Financial Revenue and admissions growth – Review Underlying Revenues 2017 2016 Underlying Total Group £m £m growth % growth % PMI 394.9 401.1 (1.6)% (0.8)% Self pay 175.4 156.6 12.0% 9.6% NHS 281.2 282.6 (0.5)% (1.9)% Other 29.6 31.8 (6.8)% (6.3)% Total revenues 881.1 872.1 1.0% 0.6% Admissions 2017

  14. Slide 14: NHS revenues analysis – Underlying

    Financial NHS revenues analysis – Review Underlying Underlying revenues 2017 2016 Growth % £m £m eReferral 241.9 229.4 5.5% NHS Local Contract 39.2 53.1 (26.2)% NHS total revenues 281.2 282.6 (0.5)% Underlying revenue growth rate H2 2017 H1 2017 H2 2016 % % % eReferral 0.9% 10.2% 15.6% NHS Local Con

  15. Slide 15: Revenue bridge by payor – Underlying

    Financial Revenue bridge by payor – Review Underlying Underlying revenues 2016 Volume Rate OPD 2017 £m £m £m £m £m PMI 401.1 (11.9) 6.4 (0.7) 394.9 Self pay 156.6 7.6 8.5 2.7 175.4 NHS 282.6 (4.1) 2.8 (0.1) 281.2 Totals 840.3 (8.4) 17.7 (1.9) 851.5 (Group revenue excl. other revenues) Day case % adm

  16. Slide 16: Trading margin analysis – Underlying

    Financial Trading margin analysis – Review Underlying Costs as % revenues - Underlying 2017 2016 % % Clinical staff costs 18.8% 18.1% Direct costs 21.9% 21.7% Medical fees 11.1% 11.7% Cost of sales 51.8% 51.5% Costs as % revenues – Underlying 2017 2016 % % Gross margin 48.2% 48.5% Hospital & corpora

  17. Slide 17: Exceptional costs

    Financial Exceptional costs Review Exceptional Costs 2017 £m Paterson settlement and related 28.7 Baddow Treatment Centre 11.1 Hospital Set-Up and Closure Costs 3.4 Strategic Review 3.3 Other 2.2 Total 48.7 Note: Additional to the above, £500k of costs associated with initial phase of achieving GDPR

  18. Slide 18: Cash flow for the period

    Financial Cash flow for the period Review 2017 2016 £m £m Operating cash flow before exceptionals and tax 158.4 186.3 Exceptional items (31.3) (5.9) Taxation (3.1) (3.0) Net cash used in investing activities (118.3) (149.9) Net cash used in financing activities (34.4) (38.5) Net increase / (decrease

  19. Slide 19: Cash flow for the period

    Financial Cash flow for the period Review 2017 2016 £m £m Operating cash flow before exceptionals and tax 158.4 186.3 EBITDA 150.0 162.0 Cash conversion of EBITDA 105.6% 115.0% 19 www.spirehealthcare.com

  20. Slide 20: The Spire Opportunity

    The Spire Opportunity Photo from AR 3 Justin Ash, Chief Executive Officer 20 www.spirehealthcare.com

  21. Slide 21: What you will hear today

    The Spire What you will hear today Opportunity Sector Vision Outlook Opportunity & Spire for for for today Spire 2018 2022 21 www.spirehealthcare.com

  22. Slide 22: Independent Sector today

    The Spire Independent Sector today Opportunity The sector opportunity is substantial and Spire now has the strategy to seize it  Demand for UK healthcare provision will continue to rise rapidly  NHS waiting lists (especially for elective work), rationing and restrictions are growing  Increasingly

  23. Slide 23: Spire today

    The Spire Spire today Opportunity Spire is well run – and will benefit from stronger operational focus  Overall  Growth  Well run, good hospital infrastructure  Good Self-Pay growth; Improvement  Well funded/cash generative potential  Operational upside  NHS well-managed in volatile market 

  24. Slide 24: Our Vision for Spire – Achievement of excellence

    The Spire Our Vision for Spire – Opportunity Achievement of excellence “To become the go-to UK independent healthcare brand, famous for clinical quality and customer care” 24 www.spirehealthcare.com

  25. Slide 25: Our Vision for Spire – Strategic goals and Key enablers

    The Spire Our Vision for Spire – Opportunity Strategic goals and Key enablers Strategic goals Key enablers  Become Famous for Quality & Clinical Care  Become Best Place to Practise  Drives referrals and customer  Consultant supply drives growth perception  Become Best Place to Work  Most Recom

  26. Slide 26: Our Vision for Spire – Outcomes

    The Spire Our Vision for Spire – Opportunity Outcomes What clinical and operational excellence will deliver  Leadership in clinical quality and customer care  Growth through Private  Lower Capex, focus on developing & optimising existing sites  More consistent and reliable performance  Improved

  27. Slide 27: Payor groups - Medium term outlook & goals

    The Spire Payor groups - Opportunity Medium term outlook & goals NHS PMI Self-Pay Market: cost management/ Market: volumes likely flat or Market: growth to continue, triage by Trusts will reduce slightly down, with increase in with consumer demand rising overall market; although Average Revenue Per

  28. Slide 28: New hospitals - 2018 outlook

    The Spire New hospitals - Opportunity 2018 outlook Spire Manchester Spire St Anthony’s Spire Nottingham  CQC inspection awaited  “Good” CQC now  CQC report awaited awarded  Improve consultant  Target key new support, attract new  Re-engineered clinical consultants consultants staff cost base 

  29. Slide 29: Changes in Capex focus

    The Spire Changes in Opportunity Capex focus 2018 2019 onwards Complete commitments; invest in Private Investment in existing estate  Total 2018 Capex budget of £100m  Upgrade of Private environment and (net) (2017: £120m) assets (e.g. diagnostics)  Continuous upgrade Capex of c.£55m,  Capacity

  30. Slide 30: Outlook for Financial Year 2018

    The Spire Outlook for Opportunity Financial Year 2018 Full year 2018 EBITDA outcome expected to be in line with 2017  Payor group expectations for 2018:  Self-Pay: Continued strong growth  PMI: Broadly flat  NHS: eReferral flat (including tariff effect), Local Contract work further declines from

  31. Slide 31: Measuring Spire's Strategic Vision

    The Spire Measuring Spire’s Opportunity Strategic Vision Key priority Measure 2017 Actual 2022 Vision Famous for Good/Outstanding 69% 100% Clinical Quality PHIN data quality N/A Leading sector Most Friends & Family 98% 100% Recommended “Extremely likely” 85% 95% First Choice for Self-Pay Growth 12%

  32. Slide 32: Spire's 2022 Vision

    The Spire Spire’s Opportunity 2022 Vision Clinical Quality/ Annual Private Customer Care EBITDA revenues = = = 100% £200m 80% of total 32 www.spirehealthcare.com

  33. Slide 33: Questions

    Questions 33 www.spirehealthcare.com

  34. Slide 34: 2017 Financial Year Results Presentation

    2017 Financial Year Results Presentation www.spirehealthcare.com

Spire Healthcare Group — FY2017 Earnings Presentation on 6ix